Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 14, 2005; 11(18): 2822-2826
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2822
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2822
Table 6 Comparison of the density of proliferation and apoptosis with severe dysplasia in the model-agent group, sulindac-preventative group and sulindac-curative group (number/mm2).
Group | n | Proliferative cell density (mean±SD) | Apoptotic cell density (mean±SD) | Ratio (apoptosis/proliferation) |
Model | 8 | 159.0±45.9 | 61.0±24.6 | 0.38 |
Preventive | 3 | 155.8±31.9 | 88.5±14.6 | 0.57 |
Curative | 5 | 159.8±22.7 | 64.2±19.1 | 0.4 |
- Citation: Sun BC, Zhao XL, Zhang SW, Liu YX, Wang L, Wang X. Sulindac induces apoptosis and protects against colon carcinoma in mice. World J Gastroenterol 2005; 11(18): 2822-2826
- URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2822.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i18.2822